论文信息 - Response to Rituximab Induction Is a Predictive Biomarker in Post-Transplant Lymphoproliferative Disorder (PTLD) and Allows Successful Treatment Stratification in an International Phase II Trial Including 152 Patients - 字舞流文

Response to Rituximab Induction Is a Predictive Biomarker in Post-Transplant Lymphoproliferative Disorder (PTLD) and Allows Successful Treatment Stratification in an International Phase II Trial Including 152 Patients

G. Salles | J. Zaucha | P. Reinke | H. Riess | A. Hüttmann | U. Dührsen | G. Verhoef | V. Leblond | M. Dreyling | V. Kliem | T. Tousseyn | S. Choquet | O. Gheysens | I. Hauser | M. Subklewe | F. Morschhauser | R. Trappe | D. Dierickx | P. Mollee | I. Anagnostopoulos | C. Tarella | H. Zimmermann | E. Neste